by jmundell@parthenonmgmt.com | Oct 17, 2024
> > Register Now << The CDC currently estimates that nearly 1 in 5 children have a developmental or psychiatric disorder; yet evidence-based, targeted treatments for these disorders are lacking. Taking an Experimental Therapeutics approach, the research...
by jmundell@parthenonmgmt.com | Oct 17, 2024
> > Register Now << Electroconvulsive therapy (ECT) is a highly effective treatment for major depression. However, it is underused due to stigma and concern over its side effects on memory. This webinar will describe the history of ECT including its many...
by jmundell@parthenonmgmt.com | Oct 17, 2024
> > Register Now << The United States is in the midst of a crisis of suicide, and TMS providers often must confront this directly. In this presentation, Dr. Philip will provide a brief overview of the existing TMS protocols used to reduce suicidal...
by Amanda Brahlek | Oct 16, 2024
> > Register Now << Although not labeled as such by the FDA, TMS is considered a third line treatment by many practitioners and health insurance company policies. Earlier referral to TMS is not commonly practiced but may be non-inferior to or superior to...
by jmundell@parthenonmgmt.com | Aug 15, 2024
> > Register Now << The CTMSS Insurance Committee presents: "TMS Documentation: Expert Perspectives". In this panel discussion, we will discuss the range of approaches when it comes to documenting TMS sessions. We will also explore how the documentation...